Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of a Clinical and Polygenic Risk Prediction Model for Ovarian Cancer in the Nurses' Health Study.

Cancer prevention research (Philadelphia, Pa.)·2025
Same author

A survey on deep learning for polygenic risk scores.

Briefings in bioinformatics·2025
Same author

Colorectal cancer risk prediction using a simple multivariable model.

PloS one·2025
Same author

Cancer incidence inconsistency between UK Biobank participants and the population: a prospective cohort study.

BMC medicine·2025
Same author

Utility of a Multi-Marker Panel with Ultrasound for Enhanced Classification of Adnexal Mass.

Cancers·2024
Same author

Mammographic Texture versus Conventional Cumulus Measure of Density in Breast Cancer Risk Prediction: A Literature Review.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2024

Related Experiment Video

Updated: Jun 17, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

755

Predicting 10-Year Risk of Pancreatic Cancer Using a Combined Genetic and Clinical Model.

Gillian S Dite1, Erika Spaeth2, Chi Kuen Wong1

  • 1Genetic Technologies Limited, Fitzroy, Victoria, Australia.

Gastro Hep Advances
|August 12, 2024
PubMed
Summary

A new combined risk score accurately identifies individuals at high risk for pancreatic cancer. This model integrates genetic and clinical factors, enabling targeted early detection strategies for improved survival rates.

Keywords:
Clinical RiskPancreatic CancerPolygenic Risk ScoreRisk Prediction

More Related Videos

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

2.7K
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.7K

Related Experiment Videos

Last Updated: Jun 17, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

755
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

2.7K
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.7K

Area of Science:

  • Oncology
  • Genetics
  • Epidemiology

Background:

  • Pancreatic cancer has a low survival rate, but early detection improves outcomes.
  • Population-wide screening is not feasible due to the cancer's rarity.
  • Accurate risk stratification can identify individuals for targeted early detection.

Purpose of the Study:

  • To validate a combined risk prediction model for pancreatic cancer.
  • To integrate a polygenic risk score with a clinical risk model for improved accuracy.

Main Methods:

  • Prospective cohort study using UK Biobank data.
  • Assessment of 10-year pancreatic cancer risk using polygenic, clinical, and combined scores.
  • Evaluation of association, discrimination, calibration, and reclassification.

Main Results:

  • The combined risk score demonstrated superior discrimination (C-index 0.714) compared to individual scores.
  • Calibration analysis showed minimal dispersion and slight risk overestimation for the combined score.
  • Individuals in the top risk decile had 1.413 times the population risk.

Conclusions:

  • The combined risk score effectively identifies individuals at substantially increased risk of pancreatic cancer.
  • This model can guide targeted screening efforts towards high-risk populations.
  • Improved risk stratification is key for enhancing early detection and survival in pancreatic cancer.